Profile data is unavailable for this security.
About the company
Zhejiang Starry Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of pharmaceutical specialty raw materials. The Company's business includes the production and sales of intermediates, APIs and preparations of iodine contrast agent series products such as iohexol, iopamidol, iodixanol, iomeprol, ioversol and iopromide. The Company's main products are non-ionic iodine contrast agent series drugs, levofloxacin series products, levofloxacin APIs and intermediates.
- Revenue in CNY (TTM)2.37bn
- Net income in CNY13.89m
- Incorporated1997
- Employees1.85k
- LocationZhejiang Starry Pharmaceutical Co LtdXianjuTAIZHOU 317306ChinaCHN
- Phone+86 57 687718605
- Fax+86 57 687718686
- Websitehttp://www.starrypharm.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lionco Pharmaceutical Group Co Ltd | 277.20m | -101.80m | 4.33bn | 475.00 | -- | 5.06 | -- | 15.61 | -0.144 | -0.144 | 0.3828 | 1.19 | 0.1843 | 2.48 | 4.41 | 583,571.30 | -6.77 | 0.7396 | -7.85 | 0.9562 | 41.77 | 80.88 | -36.73 | 2.08 | 4.94 | -4.74 | 0.2409 | 521.93 | -31.95 | -34.79 | 22.65 | -- | -33.18 | -- |
| Chengdu Olymvax Biopharmaceuticals Inc | 530.47m | -8.70m | 4.34bn | 471.00 | -- | 4.77 | -- | 8.19 | -0.0219 | -0.0219 | 1.31 | 2.24 | 0.3301 | 0.3685 | 1.04 | 1,126,255.00 | -0.9143 | 3.17 | -1.28 | 4.68 | 94.19 | 93.00 | -2.77 | 7.44 | 1.67 | -0.5392 | 0.2915 | 9.82 | -9.38 | 45.40 | -33.94 | -- | 56.47 | -- |
| Tibet Weixinkang Pharmaceutical Co Ltd | 1.26bn | 247.04m | 4.35bn | 701.00 | 17.61 | 2.94 | -- | 3.47 | 0.5677 | 0.5677 | 2.89 | 3.41 | 0.6778 | 16.41 | 5.56 | 1,791,483.00 | 13.33 | 8.20 | 17.01 | 11.13 | 53.45 | 50.20 | 19.67 | 11.53 | 3.27 | -- | 0.0075 | 59.11 | -5.43 | 12.13 | 20.94 | 23.85 | -5.61 | 38.96 |
| Zhejiang Shouxiangu Pharmaceuticl Co Ltd | 713.75m | 233.79m | 4.40bn | 1.14k | 18.59 | 1.97 | -- | 6.16 | 1.19 | 1.19 | 3.63 | 11.26 | 0.2367 | 0.7194 | 7.25 | 624,455.80 | 7.75 | 10.04 | 9.09 | 11.63 | 80.01 | 83.66 | 32.75 | 28.29 | 3.48 | -- | 0.2098 | 47.86 | -5.39 | 8.93 | -8.39 | 18.78 | 12.23 | 17.13 |
| Zhejiang Starry Pharmaceutical Co Ltd | 2.37bn | 13.89m | 4.45bn | 1.85k | 202.11 | 1.67 | -- | 1.88 | 0.0502 | 0.0502 | 5.72 | 6.08 | 0.4094 | 1.74 | 6.76 | 1,284,337.00 | 0.2471 | 3.30 | 0.4806 | 5.97 | 21.35 | 32.35 | 0.6036 | 8.21 | 0.4855 | 1.21 | 0.4994 | 53.08 | 3.04 | 19.78 | 158.32 | -13.94 | 10.39 | -- |
| Shanghai New World Co Ltd | 1.13bn | 45.48m | 4.55bn | 1.20k | 100.00 | 1.08 | -- | 4.01 | 0.0703 | 0.0703 | 1.75 | 6.53 | 0.201 | 3.94 | 10.25 | 942,735.10 | 0.7905 | 0.5242 | 1.05 | 0.7249 | 38.77 | 33.70 | 3.93 | 2.71 | 1.57 | -- | 0.1158 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
| Yabao Pharmaceutical Group Co Ltd | 2.83bn | 220.70m | 4.56bn | 4.14k | 20.71 | 1.54 | -- | 1.61 | 0.3057 | 0.3057 | 3.86 | 4.10 | 0.7389 | 3.51 | 6.66 | 683,686.80 | 5.11 | 2.82 | 6.38 | 3.97 | 52.85 | 59.20 | 6.92 | 4.19 | 2.04 | 129.51 | 0.0313 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
| Pulike Biological Engineering Inc | 1.09bn | 101.68m | 4.62bn | 1.68k | 45.08 | 1.73 | -- | 4.25 | 0.296 | 0.296 | 3.13 | 7.72 | 0.3373 | 2.48 | 2.65 | 646,748.50 | 3.16 | 7.64 | 3.73 | 8.96 | 60.45 | 62.57 | 9.36 | 17.85 | 2.51 | -- | 0.0086 | 52.48 | 1.84 | 15.55 | 3.99 | 5.17 | 41.58 | 18.47 |
Data as of Nov 22 2024. Currency figures normalised to Zhejiang Starry Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
12.46%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2024 | 7.89m | 2.31% |
| Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 2024 | 7.17m | 2.10% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 6.98m | 2.04% |
| E Fund Management Co., Ltd.as of 30 Sep 2024 | 6.31m | 1.84% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 5.13m | 1.50% |
| Galaxy Asset Management Co., Ltd.as of 30 Jun 2024 | 2.39m | 0.70% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 2.29m | 0.67% |
| Essence Fund Co., Ltd.as of 30 Jun 2024 | 2.23m | 0.65% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 1.18m | 0.35% |
| Tebon Fund Management Co. Ltd.as of 30 Jun 2024 | 1.08m | 0.31% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
